Xconomy National

Archives

by in

Entry	Author	Date	Location
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy	Bruce V. Bigelow	02/03/12	San Diego
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says	Luke Timmerman	02/01/12	Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug	Luke Timmerman	01/31/12	Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition	Luke Timmerman	12/15/11	Boston
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year	Luke Timmerman	10/19/11	Boston
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science	Stewart Lyman	09/07/11	Seattle
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments	Arlene Weintraub	08/15/11	Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News	Erin Kutz	04/01/11	Boston
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News	Bruce V. Bigelow	03/31/11	San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter	Gregory T. Huang	03/31/11	Boston
Vertex CF Drug Shines in Late-Stage Study in Children	Ryan McBride	03/29/11	Boston
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again	Luke Timmerman	03/21/11	National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised	Luke Timmerman	03/14/11	National
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London	Luke Timmerman	03/09/11	Seattle
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News	Erin Kutz	02/25/11	Boston
Vertex Stock Up 15 Percent on CF Data	Ryan McBride	02/23/11	Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug	Luke Timmerman	02/23/11	Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments	Ryan McBride	01/27/11	Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News	Erin Kutz	01/21/11	Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug	Ryan McBride	01/19/11	Boston
ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells	Erin Kutz	10/04/10	Boston
Genzyme Boss Henri Termeer Not Ready To Sell to Sanofi, Ride Into the Sunset, Sources Say	Ryan McBride	09/22/10	Boston
Good Start Genetics Emerges from Stealth with $18M Series A Round	Ryan McBride	09/10/10	Boston
PacBio Seeks $200M IPO, Complete Genomics Adds $39M, Siluria Envisions Cleaner Plastics, & More Bay Area Life Sciences News	Luke Timmerman	08/20/10	San Francisco
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader	Luke Timmerman	08/17/10	San Francisco
Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas	Luke Timmerman	08/05/10	Seattle
Lucky 13: Xconomy Boston’s Top Stories of 2010 (So Far)	Gregory T. Huang	07/23/10	Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News	Erin Kutz	07/09/10	Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal	Ryan McBride	07/08/10	Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug	Ryan McBride	07/02/10	Boston
Page 1 of 3	next page »